Advanced Search
    CAO Liangong, SHAO Zhongbai, JIANG Kaijun, WANG Youxian, LIU Shuhao, LIU Weiwei. Progress of Favipiravir: The Potential Anti SARS-CoV-2 Drug[J]. Chinese Journal of Modern Applied Pharmacy, 2020, 37(7): 769-776. DOI: 10.13748/j.cnki.issn1007-7693.2020.07.001
    Citation: CAO Liangong, SHAO Zhongbai, JIANG Kaijun, WANG Youxian, LIU Shuhao, LIU Weiwei. Progress of Favipiravir: The Potential Anti SARS-CoV-2 Drug[J]. Chinese Journal of Modern Applied Pharmacy, 2020, 37(7): 769-776. DOI: 10.13748/j.cnki.issn1007-7693.2020.07.001
    shu

    Progress of Favipiravir: The Potential Anti SARS-CoV-2 Drug

      Graphical Abstract
      • Abstract
    • The outbreak of COVID-19 poses a great threat to human. Favipiravir is a broad-spectrum antiviral drug with a novel mechanism. As a potential drug against SARS-CoV-2, favipiravir is currently conducting clinical trials. This article reviews the structure, mechanism, pharmacokinetics, antiviral activity and synthetic methods of fapilavir, in order to provide a reference for antiviral therapy.
      • FullText(HTML)
    • loading
      • References (56)
      • Related Articles

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return